Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carsten Bokemeyer

Showing results (521-530 of 664) with videos related to

Pageof 67
Sort By:
Journal of the National Cancer Institute|June 30, 2012
Role of interleukin 16 in multiple myelomaDjordje Atanackovic, York Hildebrandt, Julia Templin, et al.
Blood|September 30, 2006
Hypusination of eukaryotic initiation factor 5A (eIF5A): a novel therapeutic target in BCR-ABL-positive leukemias identified by a proteomics approachStefan Balabanov, Artur Gontarewicz, Patrick Ziegler, et al.
European Journal of Cancer (Oxford, England : 1990)|August 22, 2022
Trajectories of body weight change and survival among patients with mCRC treated with systemic therapy: Pooled analysis from the ARCAD databaseJan Franko, Jun Yin, Richard A Adams, et al.
Human Vaccines & Immunotherapeutics|August 20, 2013
The trifunctional antibody catumaxomab amplifies and shapes tumor-specific immunity when applied to gastric cancer patients in the adjuvant settingDjordje Atanackovic, Henrike Reinhard, Sabrina Meyer, et al.
European Journal of Cancer (Oxford, England : 1990)|October 16, 2012
The feasibility of triple-drug chemotherapy combination in older adult patients with oesophagogastric cancer: a randomised trial of the Arbeitsgemeinschaft Internistische Onkologie (FLOT65+)Salah-Eddin Al-Batran, Claudia Pauligk, Nils Homann, et al.
Scientific Reports|June 20, 2020
Urupocidin C: a new marine guanidine alkaloid which selectively kills prostate cancer cells via mitochondria targetingSergey A Dyshlovoy, Ekaterina K Kudryashova, Moritz Kaune, et al.
International Journal of Cancer|December 8, 2016
T-cell diversification reflects antigen selection in the blood of patients on immune checkpoint inhibition and may be exploited as liquid biopsy biomarkerNuray Akyüz, Anna Brandt, Alexander Stein, et al.
Cancer Research|April 21, 2018
Blockade of Myeloid-Derived Suppressor Cell Expansion with All-<i>Trans</i> Retinoic Acid Increases the Efficacy of Antiangiogenic TherapyRaimund Bauer, Florian Udonta, Mark Wroblewski, et al.
Cancers|September 4, 2020
Second-Generation Antiandrogen Therapy Radiosensitizes Prostate Cancer Regardless of Castration State through Inhibition of DNA Double Strand Break RepairMohamed E Elsesy, Su Jung Oh-Hohenhorst, Anastassia Löser, et al.
Molecular & Cellular Proteomics : MCP|August 14, 2012
Protein-protein-interaction network organization of the hypusine modification systemHenning Sievert, Simone Venz, Oscar Platas-Barradas, et al.
Pageof 67

Showing results (521-530 of 664) with videos related to

Sort By:
Pageof 67
Journal of the National Cancer Institute|June 30, 2012
Role of interleukin 16 in multiple myelomaDjordje Atanackovic, York Hildebrandt, Julia Templin, et al.
Blood|September 30, 2006
Hypusination of eukaryotic initiation factor 5A (eIF5A): a novel therapeutic target in BCR-ABL-positive leukemias identified by a proteomics approachStefan Balabanov, Artur Gontarewicz, Patrick Ziegler, et al.
European Journal of Cancer (Oxford, England : 1990)|August 22, 2022
Trajectories of body weight change and survival among patients with mCRC treated with systemic therapy: Pooled analysis from the ARCAD databaseJan Franko, Jun Yin, Richard A Adams, et al.
Human Vaccines & Immunotherapeutics|August 20, 2013
The trifunctional antibody catumaxomab amplifies and shapes tumor-specific immunity when applied to gastric cancer patients in the adjuvant settingDjordje Atanackovic, Henrike Reinhard, Sabrina Meyer, et al.
European Journal of Cancer (Oxford, England : 1990)|October 16, 2012
The feasibility of triple-drug chemotherapy combination in older adult patients with oesophagogastric cancer: a randomised trial of the Arbeitsgemeinschaft Internistische Onkologie (FLOT65+)Salah-Eddin Al-Batran, Claudia Pauligk, Nils Homann, et al.
Scientific Reports|June 20, 2020
Urupocidin C: a new marine guanidine alkaloid which selectively kills prostate cancer cells via mitochondria targetingSergey A Dyshlovoy, Ekaterina K Kudryashova, Moritz Kaune, et al.
International Journal of Cancer|December 8, 2016
T-cell diversification reflects antigen selection in the blood of patients on immune checkpoint inhibition and may be exploited as liquid biopsy biomarkerNuray Akyüz, Anna Brandt, Alexander Stein, et al.
Cancer Research|April 21, 2018
Blockade of Myeloid-Derived Suppressor Cell Expansion with All-<i>Trans</i> Retinoic Acid Increases the Efficacy of Antiangiogenic TherapyRaimund Bauer, Florian Udonta, Mark Wroblewski, et al.
Cancers|September 4, 2020
Second-Generation Antiandrogen Therapy Radiosensitizes Prostate Cancer Regardless of Castration State through Inhibition of DNA Double Strand Break RepairMohamed E Elsesy, Su Jung Oh-Hohenhorst, Anastassia Löser, et al.
Molecular & Cellular Proteomics : MCP|August 14, 2012
Protein-protein-interaction network organization of the hypusine modification systemHenning Sievert, Simone Venz, Oscar Platas-Barradas, et al.
Pageof 67